- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02807584
Treatment of Wounds With a New Adhesive Foam Dressing
A Prospective, Open Study to Evaluate the Clinical Performance of a New Adhesive Foam Dressing in the Treatment of Partial Thickness Burns, Acute and Chronic Wounds.
This study will look at whether ELECT, a new adhesive foam dressing, can offer an alternative to traditional wound care methods.
Patients will be treated with ELECT for 14 days. Data relating to wound healing, the performance of the dressing and the opinion of the doctor will be collected.
The hypothesis of this study is that the ELECT foam adhesive dressing is 'fit for purpose' and will be effective at treating a variety of wounds.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Durban, South Africa, 4058
- Inkosi Albert Luthuli Central Hospital (IALCH)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
INCLUSION CRITERIA
- Participants must be ≥1 years old
- Males and females (females must not be pregnant and must use contraception if of child bearing potential)
- Participant must have a partial thickness burn, acute or chronic wound that would benefit from the application of an advanced wound dressing to help facilitate moist wound healing
- Presence of a suitable wound which can be treated with the available sizes of the ELECT Adhesive Foam Dressing (7.5cm x 7.5cm, 12.5cm x 12.5cm, 15cm x 15cm and 17.5cm x 17.5cm)
- Participant is under the direct observation of the investigator for the duration of the study (i.e the participant's wound must not be treated by another clinician throughout the duration of the study).
- The participant or the participant's legal representative is able to understand and is willing to consent to the study.
EXCLUSION CRITERIA
- Participants with a known history of poor compliance with treatment (including if the participant has a known , diagnosed emotional or neurological condition such as mental disorders/illnesses, mental retardation, drug or alcohol abuse, that would pre-empt their ability to understand and consent)
- Participants who are unable to understand the aims and objectives of the study.
- Participant is a prisoner.
- Participants with a known sensitivity to any of the constituents of the evaluation products, including polyester, polyurethane, and acrylic adhesive
- Participants with facial wounds as the reference wound
- Participants with confirmed or suspected clinically infected reference wounds (unless wounds are being treated per standard protocol for wound infection)
- Participant is likely to undergo foreseeable definitive surgery within 2 weeks from screening
- Participants where a reference wound cannot be treated in isolation from other wounds
- Participants who have participated in this evaluation previously and closed/100% healed, or have been withdrawn from the study, or any previous studies
- Participant who are employees of Smith & Nephew group companies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ELECT
Adhesive Foam Dressing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound progression, (percentage change in area) using a wound imaging measurement and wound documentation system
Time Frame: 14 days
|
using a wound imaging, measurement and wound documentation system
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage change in wound depth
Time Frame: 14 days
|
14 days
|
|
|
Percentage change in wound volume
Time Frame: 14 days
|
14 days
|
|
|
Duration of dressing wear
Time Frame: 14 days
|
14 days
|
|
|
The proportion of wounds that have 100% healed or closed by secondary intention.
Time Frame: 14 days
|
14 days
|
|
|
Assessment of exudate type and amount
Time Frame: 14 days
|
Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
|
14 days
|
|
Assessment of Condition of the peri-wound skin
Time Frame: 14 days
|
Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
|
14 days
|
|
Assessment of the amount of tissue and skin colour
Time Frame: 14 days
|
Assessment using a modified Bates-Jensen Would Assessment Tool1 and T.I.M.E.2,3)
|
14 days
|
|
Assessment of infection/clinical signs of infection
Time Frame: 14 days
|
Assessment using Normal Clinical practice
|
14 days
|
|
Pain on application and removal of dressing (using a Visual Analogue Scale (VAS) or FLACC scale)
Time Frame: 14 days
|
14 days
|
|
|
Reason for dressing change
Time Frame: 14 days
|
14 days
|
|
|
Ease of application and removal of the ELECT dressing using the visual analogue scale
Time Frame: 14 days
|
14 days
|
|
|
Overall clinician acceptability with the new dressing
Time Frame: 14 days
|
Measured using a questionnaire
|
14 days
|
|
Clinician acceptability with dressing performance parameters
Time Frame: 14 days
|
Measured using a questionnaire
|
14 days
|
|
Safety in use - all adverse events that occur during the study will be recorded
Time Frame: 14 days
|
14 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alessandro Andreone, MD, Inkosi Albert Luthuli Central Hospital (IALCH)
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds and Injuries
-
Solventum US LLC3MWithdrawn
-
Centre Hospitalier Universitaire de NīmesCompletedWounds and Injuries, Hands | Wounds and Injuries, Wrists | Wounds and Injuries, Feet | Wounds and Injuries, AnklesFrance
-
National Center for Gastroentestinal and Liver...CompletedNeedlestick Injuries
-
Baskent UniversityNot yet recruitingOccupational Exposure | Needlestick Injuries | Sharps Injuries
-
Superior UniversityActive, not recruitingNeedle Stick InjuriesPakistan
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingWounds and Injuries / MortalityChina
-
Assaf-Harofeh Medical CenterUnknownInjuries and Wounds
-
Karolinska InstitutetCompletedWounds and Injuries | Blast Injuries | War-Related Injuries | Gunshot WoundSweden
Clinical Trials on ELECT
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaCompletedCoronary Artery DiseaseKorea, Republic of